Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Subspecialties Cataract, Refractive, Business and Innovation, Practice Management

A Quantum Leap For IOLS

sponsored by Teleon

Cataract and refractive surgery patient expectations are at an all-time high, so it is important that doctors have the finest devices available to help patients achieve the best vision possible. An IOL that gives the patient the best and most accurate refractive outcomes, and a better functional vision for intermediate ranges following standard cataract surgery is a game changer in this field – and Teleon Surgical ticks all these boxes with the LENTIS QUANTUM.

The LENTIS QUANTUM enhanced monofocal IOL represents a substantial leap in monofocal IOL technology.

The LENTIS QUANTUM enhanced monofocal IOL represents a substantial leap in monofocal IOL technology. How? By mimicking EDoF technology for improved intermediate vision, but also by ensuring a low chance of photic phenomena. This refining innovation represents a new standard in monofocal IOL design and addresses the increasing patient demand for improved outcomes following standard cataract treatment.

The Q-zone optic design is the secret sauce that gives patients improved intermediate vision. In effect, this Q-zone mimics an extended range of focus but, because a progressive surface profile is used, there is no interruption of light focusing on the retina, as there would be with a multifocal or trifocal design. Thanks to this innovative optic concept, surgeons have the opportunity to provide patients with better refractive results and functional vision compared with aspheric monofocal IOLs.

The QUANTUM optic technology will be made available on various IOL platforms, as well as toric models, to address patients requiring astigmatism correction – and will enable Teleon Surgical to continue defining the IOL space in the future. The platform – recently launched at the ESCRS 2021 conference in Amsterdam – is available in a range between 10.0 D and 30.0 D in 0.5 D increments.

Now popular with an increasing number of surgeons globally, the LENTIS QUANTUM IOL addresses increasing patient demands to achieve better outcomes in the standard range of monofocal cataract treatments. 

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Case Study
Uncovering Ocular Comorbidity

| Contributed by Quidel

Related Product Profiles
Sulcus-based enhancement of visual quality

| Contributed by Medicontur Medical Engineering Ltd

Less Steps, More Vision

| Contributed by Medicontur Medical Engineering Ltd

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register